Stock TOI THE ONCOLOGY INSTITUTE, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus The Oncology Institute, Inc.

Equities

TOI

US68236X1000

End-of-day quote Nasdaq
Other stock markets
 23:00:00 02/05/2024 BST 		5-day change 1st Jan Change
1.07 USD -7.76% Intraday chart for The Oncology Institute, Inc. -6.96% -47.55%
04-08 The Oncology Institute, Inc. Appoints Jordan McInerney as New Chief Development Officer CI
04-04 The Oncology Institute and Healthly Forge Strategic Alliance to Elevate Cancer Care Access to Healthly Patients Across Southern California CI

Evolution of the average Target Price on The Oncology Institute, Inc.

Price target over the last 5 years

History of analyst recommendation changes

e80a5c9fd1e0b823a93c4.VLt5RD_74LU_SF7FvTQajDG8GNlMf9LA-_Ys3mXQUg4.E4gLMlO_0_1XCwirhEFLv3PsarMHSbOlzNt4sAagCHxt2R0Kb8Oq-0Z8Zg~db86155168a8038d2fd2025d569e97bd

Analyst Recommendations on The Oncology Institute, Inc.

Guggenheim Trims Price Target on Oncology Institute to $2 From $3, Maintains Buy Rating MT
Guggenheim Adjusts Oncology Institute's Price Target to $3 From $6, Keeps Buy Rating MT
Guggenheim Adjusts Price Target on The Oncology Institute to $6 From $7, Maintains Buy Rating MT
Jefferies Starts Oncology Institute at Buy With $10 Price Target MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
1.07 USD
Average target price
2.5 USD
Spread / Average Target
+133.64%
High Price Target
2.5 USD
Spread / Highest target
+133.64%
Low Price Target
2.5 USD
Spread / Lowest Target
+133.64%

Consensus detail

Consensus revision (last 18 months)

Analysts covering The Oncology Institute, Inc.

Guggenheim
Jefferies & Co.

Quarterly revenue - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. TOI Stock
  4. Consensus The Oncology Institute, Inc.